Hualan Biological Vaccine

Hualan Biological Vaccine Co., Ltd. was founded in 2005 as a high-tech enterprise specializing in vaccine research, production, and sales. It is China’s largest influenza vaccine producer and the birthplace of the world’s first marketed H1N1 influenza vaccine. The company is also the fifth globally and the first in China to achieve WHO prequalification for influenza vaccines.

Walvax Biotechnology reports a **90%+ year-on-year net profit collapse**, swinging to a loss in Q3 2026 amid China’s VAT hike. Meanwhile, **CanSino and Kangtai Biological expand revenue and profit**, driven by surging overseas demand. The sector’s performance gap widens as domestic headwinds force reliance on international markets for growth.

Oct 2026BigGo FinanceNews article

China’s A-share market shows mixed performance on August 21, with precious metals stocks driving gains. The Shanghai Composite Index rises slightly to **3,905.2 points**, while the Shenzhen Component Index climbs **0.87%** and the tech-focused ChiNext Index gains **1.43%**. Meanwhile, pharmaceutical stocks decline amid broader sector volatility.

Aug 2026BigGo FinanceNews article

China’s National Health Security Administration (NHSA) and Ministry of Finance now allow flu vaccinations to be covered under employee basic medical insurance via designated retail pharmacies. This policy change marks the first time flu shots are included in public health expenditure, potentially easing access to vaccinations. The framework introduces a whitelist system for approved pharmacy payments, expanding coverage beyond traditional institutional boundaries.

May 2026BigGo FinanceNews article

China’s National Healthcare Security Administration and Ministry of Finance now allow employee medical insurance personal accounts to cover flu vaccines under a new policy. The move has driven demand for domestic vaccine producers like Hualan Biological and GDK Biopharma, whose stocks surged over 3%. Local authorities can designate retail pharmacies to administer vaccinations using these funds, expanding access to preventive healthcare.

May 2026BigGo FinanceNews article